Quadrature Capital’s Agilon Health AGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$872K Buy
+8,139
New +$533K 0.01% 783
2025
Q4
– Sell
-6,155
Closed -$158K – 1230
2025
Q3
$158K Buy
+6,155
New +$233K ﹤0.01% 820
2025
Q2
– Sell
-2,589
Closed -$280K – 1013
2025
Q1
$280K Buy
2,589
+702
+37% +$61.1K 0.01% 757
2024
Q4
$89.4K Sell
1,887
-775
-29% -$46.9K ﹤0.01% 927
2024
Q3
$261K Buy
+2,662
New +$344K 0.01% 689
2024
Q2
– Sell
-1,215
Closed -$185K – 1096
2024
Q1
$185K Buy
+1,215
New +$202K ﹤0.01% 1056
2022
Q4
– Sell
-1,065
Closed -$624K – 829
2022
Q3
$624K Buy
+1,065
New +$638K 0.02% 463

Other funds holding AGL

Quadrature Capital's AGL Position: Q2 2026 in Review

Quadrature Capital opened a new position in Agilon Health (AGL) in Q2 2026: 8,139 shares worth $872K. The stake represents 0.01% of the portfolio and ranks #783 among its holdings. This is a return to the name: Quadrature Capital previously reported a position in AGL as recently as Q3 2025.

Quadrature Capital first reported a position in AGL in Q3 2022 and has held it in 7 quarters since. 179 funds tracked by Wall St. Rank hold AGL as of Q2 2026.

  • Quadrature Capital held 8,139 shares of Agilon Health worth $872K as of Q2 2026.
  • Agilon Health was a new Quadrature Capital position in Q2 2026.
  • Agilon Health made up 0.01% of Quadrature Capital's portfolio in Q2 2026, its #783 holding.
  • Quadrature Capital first reported a position in Agilon Health in Q3 2022 and has held it in 7 quarters since.
  • 179 funds tracked by Wall St. Rank held Agilon Health as of Q2 2026.

Based on Quadrature Capital's 13F filing for Q2 2026, filed 7 Aug 2026.